These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9460126)

  • 1. Image interpretation session: 1997. Multiple sclerosis (MS).
    Radiographics; 1998; 18(1):224-8. PubMed ID: 9460126
    [No Abstract]   [Full Text] [Related]  

  • 2. Uncovering and characterizing multiple sclerosis lesions: the aid of fluid-attenuated inversion recovery images in the presence of gadolinium contrast agent.
    Bagnato F
    J Neuroimaging; 2009 Jul; 19(3):201-4. PubMed ID: 19187471
    [No Abstract]   [Full Text] [Related]  

  • 3. Fat-saturated post gadolinium T1 imaging of the brain in multiple sclerosis.
    Al-Saeed O; Ismail M; Athyal R; Sheikh M
    Acta Radiol; 2011 Jun; 52(5):570-4. PubMed ID: 21498296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Magnetic resonance tomography with gadolinium DTPA in multiple sclerosis. Findings in initial manifestation and later disease stages].
    Rüttinger H; Hermes M
    Nervenarzt; 1990 Jun; 61(6):356-60. PubMed ID: 2377261
    [No Abstract]   [Full Text] [Related]  

  • 5. Multiple sclerosis disease activity correlates with gadolinium-enhanced magnetic resonance imaging.
    Gonzalez-Scarano F; Grossman RI; Galetta S; Atlas SW; Silberberg DH
    Ann Neurol; 1987 Mar; 21(3):300-6. PubMed ID: 3606036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Magnetic resonance tomography of non-acute multiple sclerosis before and after use of a contrast medium (Gd-DTPA)].
    Gowin W; Weihe W; Appel C; Mariss G
    Rontgenpraxis; 1986 Nov; 39(11):367-77. PubMed ID: 3810314
    [No Abstract]   [Full Text] [Related]  

  • 7. Characteristic neuroimaging in patients with tumefactive demyelinating lesions exceeding 30 mm.
    Kiriyama T; Kataoka H; Taoka T; Tonomura Y; Terashima M; Morikawa M; Tanizawa E; Kawahara M; Furiya Y; Sugie K; Kichikawa K; Ueno S
    J Neuroimaging; 2011 Apr; 21(2):e69-77. PubMed ID: 20572907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multiple sclerosis: serial study of gadolinium-enhanced MR imaging.
    Grossman RI; Braffman BH; Brorson JR; Goldberg HI; Silberberg DH; Gonzalez-Scarano F
    Radiology; 1988 Oct; 169(1):117-22. PubMed ID: 3420246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing brain MRI protocols in the follow-up of patients with multiple sclerosis T2-weighted MRI of the brain after the administration of gadopentetate dimeglumine.
    Taschner CA; Kirsch EC; Scheffler K; Wetzel SG; Schulte-Mönting J; Kappos L; Radü EW
    Magn Reson Imaging; 2005 Apr; 23(3):469-74. PubMed ID: 15862648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relapsing-remitting multiple sclerosis: sequential enhanced MR imaging vs clinical findings in determining disease activity.
    Barkhof F; Scheltens P; Frequin ST; Nauta JJ; Tas MW; Valk J; Hommes OR
    AJR Am J Roentgenol; 1992 Nov; 159(5):1041-7. PubMed ID: 1414773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intracranial tumor-like lesions in children and young adults with multiple sclerosis].
    Einig M; Higer HP; Mauz M; Ernst JP
    Rofo; 1992 Oct; 157(4):384-9. PubMed ID: 1391842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Magnetic resonance imaging of disseminated sclerosis].
    Christiansen AP; Wanscher B; Larsson HB; Henriksen O
    Ugeskr Laeger; 1994 Oct; 156(43):6348-52. PubMed ID: 7810007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evolution of the concentric lesions of atypical multiple sclerosis on MRI.
    Morioka C; Komatsu Y; Tsujio T; Araki Y; Kondo H
    Radiat Med; 1994; 12(3):129-33. PubMed ID: 7972897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early contrast-enhanced magnetic resonance imaging with fluid-attenuated inversion recovery in multiple sclerosis.
    Kataoka H; Taoka T; Ueno S
    J Neuroimaging; 2009 Jul; 19(3):246-9. PubMed ID: 19021828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Neuroimaging in multiple sclerosis].
    Rivera VM
    Rev Neurol; 2001 Feb 1-15; 32(3):283-5. PubMed ID: 11310287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Magnetic resonance imaging in multiple sclerosis: an overview.
    Colosimo M; Amatruda A; Cioffi RP
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):113-23. PubMed ID: 1345732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of brain lesions in a mouse model of progressive multiple sclerosis.
    Levy H; Assaf Y; Frenkel D
    Exp Neurol; 2010 Nov; 226(1):148-58. PubMed ID: 20736006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Brain magnetic resonance with magnetization transfer in multiple sclerosis. Lesion hyperintensity before and after intravenous gadolinium administration].
    Renzetti P; Parodi RC; Losacco C; Rosso E; Arcuri T; Sardanelli F
    Radiol Med; 1999 Sep; 98(3):138-43. PubMed ID: 10575442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seeing is believing: in vivo evolution of multiple sclerosis pathology with magnetic resonance.
    Ge Y
    Top Magn Reson Imaging; 2006 Aug; 17(4):295-306. PubMed ID: 17415002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroimaging and functional analyses for multiple sclerosis].
    Kira J
    Rinsho Byori; 2000 Sep; 48(9):814-22. PubMed ID: 11051795
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.